Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Multitarget Therapeutic Strategies for Alzheimer's Disease: Review on Emerging Target Combinations - Maramai_2020_Biomed.Res.Int_2020_5120230 |
| Author(s) : Maramai S , Benchekroun M , Gabr MT , Yahiaoui S |
| Ref : Biomed Res Int , 2020 :5120230 , 2020 |
| Abstract : Maramai_2020_Biomed.Res.Int_2020_5120230 |
| ESTHER : Maramai_2020_Biomed.Res.Int_2020_5120230 |
| PubMedSearch : Maramai_2020_Biomed.Res.Int_2020_5120230 |
| PubMedID: 32714977 |
| Title : A Novel in vivo Anti-amnesic Agent, Specially Designed to Express Both Acetylcholinesterase (AChE) Inhibitory, Serotonergic Subtype 4 Receptor (5-HT4R) Agonist and Serotonergic Subtype 6 Receptor (5-HT6R) Inverse Agonist Activities, With a Potential Interest Against Alzheimer's Disease - Hatat_2019_Front.Aging.Neurosci_11_148 |
| Author(s) : Hatat B , Yahiaoui S , Lecoutey C , Davis A , Freret T , Boulouard M , Claeysen S , Rochais C , Dallemagne P |
| Ref : Front Aging Neurosci , 11 :148 , 2019 |
| Abstract : Hatat_2019_Front.Aging.Neurosci_11_148 |
| ESTHER : Hatat_2019_Front.Aging.Neurosci_11_148 |
| PubMedSearch : Hatat_2019_Front.Aging.Neurosci_11_148 |
| PubMedID: 31316368 |
| Title : Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer's disease - Yahiaoui_2016_Eur.J.Med.Chem_121_283 |
| Author(s) : Yahiaoui S , Hamidouche K , Ballandonne C , Davis A , de Oliveira Santos JS , Freret T , Boulouard M , Rochais C , Dallemagne P |
| Ref : Eur Journal of Medicinal Chemistry , 121 :283 , 2016 |
| Abstract : Yahiaoui_2016_Eur.J.Med.Chem_121_283 |
| ESTHER : Yahiaoui_2016_Eur.J.Med.Chem_121_283 |
| PubMedSearch : Yahiaoui_2016_Eur.J.Med.Chem_121_283 |
| PubMedID: 27266998 |
| Title : Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT4R) agonist activities as potential agents against Alzheimer's disease: the design of donecopride - Rochais_2015_J.Med.Chem_58_3172 |
| Author(s) : Rochais C , Lecoutey C , Gaven F , Giannoni P , Hamidouche K , Hedou D , Dubost E , Genest D , Yahiaoui S , Freret T , Bouet V , Dauphin F , Sopkova de Oliveira Santos J , Ballandonne C , Corvaisier S , Malzert-Freon A , Legay R , Boulouard M , Claeysen S , Dallemagne P |
| Ref : Journal of Medicinal Chemistry , 58 :3172 , 2015 |
| Abstract : Rochais_2015_J.Med.Chem_58_3172 |
| ESTHER : Rochais_2015_J.Med.Chem_58_3172 |
| PubMedSearch : Rochais_2015_J.Med.Chem_58_3172 |
| PubMedID: 25793650 |